← All trials
NCT07283367
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 19, 2025
- Primary completion
- Dec 31, 2029
- Completion date
- Dec 31, 2029
- First posted
- Dec 15, 2025
- Last posted
- Dec 15, 2025
- Enrollment
- 502
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jiangsu Hansoh Pharmaceutical Co., Ltd.Lead sponsor
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.